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The objective of this research was to study the effectiveness of calcitriol and ethynil ethyl estradiol combinations to decrease osteoporosis 
and endometrial cancer risks in ovariectomized Wistar rats. Twenty five 8-week old female Wistar rats were randomly divided into five groups 
(normal controlled rats/NK, ovariectomized rats/OVK, ovariectomized rats + calcitriol supplementation/OVD, ovariectomized rats + ethynil ethyl 
estradiol supplementation/OVE, and ovariectomized rats + calcitriol + ethynil ethyl estradiol supplementation/OVDE). At the end of the study, all 
rats were weighed and euthanized with 10% ketamine and 2% xylazine. Uterus and left femur were taken and fixed in 10% formaldehyde 
solution for histopathological examination using hematoxylin and eosin stain. Uterus was weighed before the fixation. The results showed that 
the percentage of uterus weight in OVK was significantly decreased compared to NK. Meanwhile, the percentage of uterus weight in OVDE was 
significantly increased compared to OVK. Histopathological features of the uterus in OVK were atrophy, reduction of myometrial and 
endometrial layers thickness, and formation of cuboidal epithelium in the endometrial lumen. However, the thickness of myometrial and 
endometrial layers in OVDE were increased, and its endometrial lumen was lined with metaplastic and hyperplastic squamous cell. 
Histopathological features of distal femur epiphysis in OVK ras showed fewer trabecular spiculums and more adipocyte in the bone marrow 
compared to NK. However, OVDE had more trabecular bone spiculum and less adipocyte in the bone marrow compared to OVK. In conclusion, 
the combination of calcitriol and ethynil ethyl estradiol supplementation could reduce osteoporosis, but increased the endometrial cancer risk in 
ovariectomized Wistar rats.  
____________________________________________________________________________________________________________________ 




Penelitian ini dilakukan untuk mengetahui efektivitas kombinasi kalsitriol dan etinil etil estradiol dalam menurunkan risiko osteoporosis dan 
kanker endometrium tikus ovariektomi. Dua puluh lima tikus Wistar betina umur delapan minggu, dibagi ke dalam lima kelompok (kontrol 
normal/NK, kontrol ovariektomi/OVK, ovariektomi+kalsitriol/OVD, ovariektomi+etinil etil estradiol/OVE, dan ovariektomi+ kombinasi 
kalsitriol dan etinil etil estradiol/OVDE) yang diberi perlakuan selama delapan minggu. Pada akhir perlakuan, tikus dieutanasia menggunakan 
campuran ketamin 10% dengan xylaxine 2%. Uterus dan femur kiri diambil, uterus ditimbang, kemudian uterus dan tulang femur kiri difiksasi 
dalam formalin 10% untuk pemeriksaan histopatologis. Hasil analisis menunjukkan prosentase berat uterus tikus OVK lebih rendah signifikan 
dibanding tikus NK, sedangkan prosentase berat uterus tikus OVDE lebih tinggi signifikan dibanding tikus OVK. Gambaran histopatologis 
uterus tikus OVK terlihat atropi, penurunan tebal lapisan endometrium dan miometrium, sel epitel lumen endometrium berbentuk kuboid, 
sedangkan tikus ovariektomi OVDE terlihat penebalan lapisan endometrium dan myometrium, sebagian lumen endometrium dilapisi sel epitel 
squamus metaplasia dan sel epitel squamus hiperplasia. Gambaran histopatologis epifisis tulang femur distalis pada tikus OVK terlihat lebih 
sedikit spikulum trabekula dan dominasi jaringan adiposit dalam rongga sumsum tulang dibanding tikus NK, sedangkan pada tikus OVDE 
terlihat mempunyai lebih banyak spikulum trabekula dan lebih sedikit adiposit dalam rongga sumsum tulang dibanding tikus OVK. Dari hasil 
penelitian dapat disimpulkan bahwa kombinasi kalsitriol dengan etinil etil estradiol pada tikus ovariektomi efektif menurunkan risiko 
osteoporosis namun meningkatkan risiko kanker endometrium.  
 
____________________________________________________________________________________________________________________ 





Low level of estrogen causes osteoporosis either in 
animals or humans. There is a relationship between low 
circulating estrogen concentrations in menopausal period 
with osteoporotic fracture in post-menopausal women 
(Doherty et al., 2001). Estrogen plays a role in the 
suppression of bone remodeling (Manolagas, 2002) by 
suppressing bone resorption, decreasing osteoclast 
production (Hughes et al., 1996; Teitelbaum, 2000), and 
inducing bone formation by increasing osteoblast 
production, despite the variation depends on its animal 
model (Qu et al., 1998). Estrogen also activates the 
kidney to convert vitamin D into its active form 
(Notelovitz, 1997). The decreased estrogen level causes 
the reduction of 1,25-dihydroxyvitamin D3 (Notelovitz, 
1997). Hormone replacement therapy using estradiol can 
inhibit bone resorption, increase bone density, and 
reduce the risk of bone fracture (Rossouw et al., 2002; 
Anderson et al., 2004). However, it may cause stroke, 
pulmonary embolism, breast cancer, and endometrial 
cancer (Rodan and Martin, 2000; Rossouw et al., 2002). 
Estradiol supplementation causes hypertrophy and 
hyperplasia of all uterus structure (Gallo et al., 2008; Pan 
et al., 2010). According to Amant et al. (2005) and Kong 
et al. (1997), endometrial hyperplasia was the precursor 
of endometrial cancer. Several study showed that 1,25-
dihydroxyvitamin D3 increased bone formation (Hendy 
et al., 2006) and decreased the risk of endometrial cancer 
(Salazar-Martinez et al., 2005; Mohr et al., 2007). 
Supplementation of 8 ng calcitriol for six weeks in 
ovariectomized rats reduced the estrogen concentration 
and cause osteoporosis, which was marked by reduced 
trabecular bone spiculum, increased bone marrow cavity, 
and domination of adipocyte tissue of the distal femur 
(Hartiningsih et al., 2012). The effect of combined 
calcitriol and ethynil ethyl estradiol in reducing 
osteoporosis and its safety for uterus in ovariectomized 




rats had never been reported. The effectiveness of 
combined calcitriol and ethynil ethyl estradiol was 
analyzed using histopathological examination of the 
distal femur and the uterus. Combined estrogen and 
ethynil ethyl estradiol are expected to reduce 
osteoporosis, which is marked by increased trabecular 
bone spiculum and reduced adipocyte tissue in bone 
marrow cavity. They are also expected to be safe for the 
uterus, with no effect of inducing hypertrophy and 
hyperplasia on the uterus structure. 
 
MATERIALS AND METHOD 
 
In this research, twenty five female Wistar rats with 
8 weeks of age were used and placed in individual 
cages with 25 C room temperature. The rats were 
given standard feeding which contained 20% protein, 
0.6% calcium, and 0.4% phosphate. The standard 
feeding, for each g/100 g, consist of 78% corn, 20% 
anchovy, 0.3% CaCO3, 0.7% molase, 1.0% mineral-
vitamin, and sufficient distilled water. 
   The rats were divided into five groups (normal 
control/NK, ovariectomized control/OVK, 
ovariectomized + 20 ng/day/rat oral calcitriol/OVD, 
ovariectomized + 25 µg/day/rat oral ethynil ethyl 
estradiol/OVE, and ovariectomized + combined 20 
ng/day/rat oral calcitriol and 25 µg/day/rat oral ethynil 
ethyl estradiol/OVDE. One week after environmental 
adaptation, ovariectomy was performed using incision 
in the caudal midline. Combination of 10% ketamine 
(50 mg/kg) and 2% xylazine (5 mg/kg) was injected  
intramuscularly for anesthesia. The same procedure 
was performed in the controlled Wistar rats without 
ovariectomy. One week after surgery, all Wistar rats 
were started to be given the treatment for eight weeks. 
At the end of treatment period, rats were weighed 
and euthanized using combination of ketamine 10% 
and xylazine 2% intramuscularly. Left femoral bone 
was taken and fixated in formalin 10% for 
histopathological examination. Before the fixation in 
formalin 10%, the uterus was weighed and the result 
was analyzed using one way Anova and Duncan’s test, 
while the result of histopathological examination was 
analyzed descriptively. 
 
RESULTS AND DISCUSSION 
 
Ovariectomy caused a significant decrease in uterus 
weight percentage of OVK rats (0.068±0.02%) 
compared to that of the NK rats (0.22±0.02%). 
Supplementation of ethynil ethyl estradiol caused 
uterus weight percentage of OVE rats (0.24±0.04%) 
increased 3.5 folds more than that of OVK rats 
(0.068±0.02%). Supplementation of combined 
calcitriol and ethynil ethyl estradiol caused uterus 
weight percentage of OVDE rats (0.17±0.03%) to 
increased 2.5 folds greater than OVK rats. 
Supplementation of calcitriol caused uterus weight 
percentage of OVD rats (0.058%±0.01%) decreased 
0.85 fold than OVK rats (Figure 1). Saruhan et al. 
(2006) reported that the ovariectomy reduced the uterus 
weight. Reduction of uterus weight percentage in OVK 
rats was reciprocal to the study by Li et al. (2003), Pan 
et al. (2010), and Gallo et al. (2008), which reported 
that ovariectomy in rats reduced serum estradiol 
concentration and uterus weight. 
 
 
Figure 1. Percentage of uterus weight (g/body weight) after 8 
weeks of treatment 
 
The higher percentage of uterus weight of OVE rats 
compared to OVK rats, and OVDE rats compared to 
OVD rats were also consistent to the study done by Li 
et al. (2003), Pan et al. (2010), and Gallo et al. (2008), 
which reported that ethynil ethyl estradiol in 
ovariectomized rats increased serum estradiol 
concentration and increased uterus weight. Uterus 
weight percentage of OVD rats, which was less than 
OVK rats, in spite of its non-significant result, was 
caused by the lower estrogen concentration in OVD 
rats compared to OVK rats. Hartiningsih et al. (2006) 
reported that supplementation of calcitriol for 3 months 
after ovariohysterectomy reduced estrogen. OVDE rats 
had a lower uterus weight percentage compared to 
OVE rats, despite its non-significant result, and was 
caused by its lower estrogen concentration compared to 
OVE rats.  
Histopathological figure of uterus in NK rats 
showed columnar endometrial epithelium, which was 
reciprocal to Saruhan et al. (2006). Histopathological 
figure of uterus in OVK and OVD rats showed atrophy, 
reduction in diameter, reduction in endometrial-
myometrial layer, and cuboidal epithelium of the uterus 
(Figure 2). Several researches showed atrophic and 
cuboidal epithelium of uterus, two months after 
ovariectomy (Sonmez et al., 2000; Saruhan et al., 2006; 
Pan et al., 2010). Histopathological figure of uterus in 
OVE and OVDE rats uterus showed an increase of 
luminal diameter and endometrial-myometrial layer. 
However, in OVE rats, endometrial lumen was lined by 
complex and hyperplastic squamous epithelium, while 
in OVDE rats, the uterus was lined by metaplastic, 
complex, and hyperplastic squamous epithelium. 
According to Pan et al. (2010) and Gallo et al. (2008), 
the supplementation of estradiol caused epithelial 
hyperplasia of the uterus, and hypertrophy in all of its 
structure. Amant et al. (2005) and Kong et al. (1997) 
reported the hyperplasia of endometrium was a 
precursor of type I endometrial cancer. Eighty percent 
of all endometrial carcinoma or type I endometrial can- 









Figure 2. Histopathological figure of normal rat uterus. A1 and A2= Lumen was lined by columnar endometrial epithelium (b), B1 and 
B2= OVK rat uterus showed reduced uterus diameter, cuboidal epithelium (a), and loose stromal, C1 and C2= OVD rat uterus showed reduced 
uterus diameter, endometrial cuboid epithelium (a), and loose stromal, D1 and D2= OVDE rat uterus, E1 and E2= Showed endometrial 
epithelium hyperplasia (b) (HE 100x) 




cer was reported to be caused by hormone replacement 
therapy or estrogen. Histopathological figure of uterus 
in OVE and OVDE rats showed an increased risk of 
endometrial cancer. 
 
Histopathological Analysis of Distal Femoral 
Epiphysis 
Histopathological analysis of distal femoral 
epiphysis of normal control rats NK showed a normal 
shape (Figure 3A), in agreement to what Jee (1983) and 
Bullock and Rosendahl (1984) have explained, that 
proximal epiphysis and distal part of long bones 
consisted of the trabeculae and the cleft that connects 
trabeculae are filled with bone marrow. The use of 
trabeculae spicules to mark the presence of osteoblast is 
in accordance with a report by Shiraishi et al. (2000) 
which stated that recruitment, osteoblast differentiation, 
and bone formation by osteoblast were marked by the 
thickening of trabeculae spicules. The use of adipose 
tissue to mark the presence of osteoclast in bone 
marrow cavity is in accordance with Rosen et al. 
(2009) whose report stated that bone marrow cavity 
was filled with hematopoietic tissue, bone tissue, and 
adipose tissue. It has been reported by Dazzi et al. 
(2006) and Minguell et al. (2001) that the balance of 
microenvironment in bone marrow is an important 
factor for hematopoietic process, osteogenesis process, 
and other processes. 
 Histopathologic analysis of distal femoral 
epiphysis of OVK rats (Figure 3B) and OVD rats 
(Figure 3C) showed a little amount of trabeculae 
spicules and the bone marrow cavity was dominated by 
adipose tissue. On OVDE rats (Figure 3D) and OVE 
rats (Figure 3E) showed more trabeculae spicules, and 
bone marrow cavity of OVE rats was dominated by 
hematopoietic tissue, while bone marrow cavity of  
OVDE rats was dominated by adipose tissue. 
Domination of adipose tissue in bone marrow cavity 
of OVK rats femoral epiphysis marked osteoporosis. It 
had been reported by Syed et al. (2008) and Benayahu 
et al. (2000) that estrogen deficiency caused an 
increase in the accumulation, number, and size of 
adipose cells in bone marrow of post-menopausal 
women that suffer from osteoporosis and 
ovariectomized mice. Domination of adipose tissue in 
bone marrow cavity of OVK rats femoral epiphysis 
marked the increasing osteoclast activity in bone 
resorption which was thought to be related to the 
 
 
Figure 3. Histopathological figure of distal epiphyseal femoral bone of NK rats (A) showed no change in trabecular spicules (s) 
and  hematopoietic cells  predominance in bone marrow cavity (h); OVK rats (B) and OVD rats  (C) were showed few trabecular 
spicules (s), and adipocytes predominance in bone marrow (a); OVDE rats (D) and OVE rats (E) were showed more trabecular 
spicules (s), adipocytes predominance in bone marrow  of  OVDE rats (a), and  hematopoietic cells  predominance in bone 
marrow cavity of  OVE rats (h)  (HE 100x) 




decreasing level of estrogen. According to Cooke and 
Naaz (2004) and Riggs et al. (2002), estrogen had a 
fundamental role in control of osteoblast and adipose 
cells. It had also been reported by Verma et al. (2002), 
Justesen et al. (2001) and Rodriguez et al. (1999) that 
the decrease of estrogen concentration affects 
proliferation and estrogenic activities in bone marrow 
and will cause a higher conversion of stromal cells into 
adipose cells rather than into osteoblasts. According to 
Weisberg et al. (2003) not only did the presence of 
adipose cells in bone marrow cavity suppress bone 
formation and inhibit osteoblastogenesis, but it also 
increase bone resorption. Some researchers reported 
that the decrease of estrogen concentration increase 
bone resorption until it exceeds bone formation 
(Manolagas et al., 2000; Khosla et al., 2002; Riggs et 
al., 2002) which causes wider resorption of trabeculae 
bone, loss of trabeculae connectivity (Manolagas et al., 
2000; Khosla et al., 2002; Riggs et al., 2002), and the 
absence of trabeculae structure (Rosen and Bouxsein, 
2006; Syed et al., 2008). The decrease of distal femoral 
bone trabecular spicules in OVK rats also marked bone 
formation. Cigiela et al. (2012) reported that 
ovariectomy decreases trabeculae spicules and causes 
bone marrow cavity to become wider. According to 
Nakamura et al. (2003) and Notelovitz (1997), in normal 
condition, bone will maintain normal blood calcium 
level through the balance between bone resorption by 
osteoclast and formation of new bone by osteoblast. 
According to some researchers, bone resorption and 
formation imbalance (Goltzman, 2002; Teitelbaum and 
Ross, 2003; Martin and Sims, 2005; Seeman et al., 2006; 
Karsdal et al., 2007), higher rate of bone resorption rate 
than that of bone formation (Doige, 1988; Palmer, 1993), 
increasing bone resorption and decreasing bone 
formation or both (Banks, 1981; Bullock and Rosendahl, 
1984; Jubb et al., 1985) might cause osteoporosis. 
Therefore,  it could be said that ovariectomy on OVK 
rats cause osteoporosis. 
Calcitriol suplementation on OVD rats caused more 
adipose tissue to form in bone marrow cavity and 
trabeculae spicules of the distal epiphyseal plate of the 
femur were decreased compared to that of the NK rats, 
but appeared to have fewer amount of adipose tissue 
and more trabeculae spicules than OVK rats (Figure 3). 
The amount of adipose tissue in the bone marrow of 
femur distal epiphyseal plate of OVD rats, which was 
lesser than that of OVK rats but greater than NK rats, 
revealed that calcitriol suplementation decrease adipose 
tissue even in OVD rats that have lower concentration 
of estrogen. It was reported by Duque et al. (2004) that 
calcitriol inhibits adipogenesis in bone marrow cavity 
by lowering the expression of peroxisome proliferator-
activated receptor gamma (PPARγ) (Duque et al., 
2004).  Zhou et al. (2006), Kong and Li (2006), and 
Sun and Zemel (2004), also reported that 1,25-
dihydroxyvitamin D3 induced apoptosis adipogenesis 
and inhibited adipogenesis in cells. Adipose tissue in 
the bone marrow cavity of femur the distal epiphyseal 
plate in OVD rats, which was lesser than that of the 
OVK rats but greater than the NK rats revealed that 
calcitriol supplementation caused OVD rats’s bone 
resorption activities become lower than that of OVK 
rats, but higher than that of NK rats. 
Trabecular spicules of femur distal epiphyseal plate 
in OVD rats, which was greater  in OVK rats but lesser 
in NK rats, thought to be related with a higher level of 
calcitriol. Chang et al. (2013) and Anderson et al. 
(2006) reported that supplementation of 1,25-
dihydroxyvitamin D3 increased preosteoblast 
proliferation to be osteoblast. Chang et al. (2013) also 
reported that supplementation of 1,25-
dihydroxyvitamin D3 caused higher marker of 
osteoclasin formation and alkaline phosphatase as well 
as caused higher mineral density of femoral and 
trabeculae femoral volume although still lower than 
rats that had been treated with estradiol. According to 
Zhou et al. (2006) 1,25-dihydroxyvitamin D3 works 
directly on osteoblast to increase bone formation. 
Therefore, in this study, calcitriol supplementation 
causes bone formation activity on OVD rats to become 
higher than that of OVK rats, even though it’s still 
lower than that of the NK rats. 
Ethynil ethyl estradiol supplementation on OVE rats 
and OVDE rats were thought to cause estrogen 
concentration of OVE rats raised above that of OVK 
rats, and estrogen concentration of OVDE rats to become 
higher than that of OVD rats. Histopathological analysis 
of OVE rats showed fewer adipose tissues in bone 
marrow cavity and more spiculum trabeculae in the 
distal epiphyseal plate of the femur than that of OVK 
rats. The same thing was occurred in OVDE rats when 
compared to OVD rats (Figure 3). The fewer number of 
adipose tissue in bone marrow cavity of OVE rats and 
OVDE rats marked a lowered activity of bone resorption 
that was thought to have a relationship with the higher 
level of estrogen. Parikka et al. (2001) and Kameda et al. 
(1997) reported that estradiol lowers osteoclast activity 
for bone resorption. The more number of trabecular 
spicules that found in femur distal epiphyseal plate of 
OVE rats and OVDE rats were considered related with 
the higher level of estrogen in OVE rats and OVDE 
rats. Some researchers reported that estrogen could 
increase bone formation by increasing osteoblast 
formation, differentiation, proliferation, and osteoblast 
function, although it depends on the animal used (Chow 
et al., 1992; Majeska et al., 1994; Qu et al., 1998).  
Chang et al. (2013) reported that estrogen has direct 
impact on osteoblast by increasing the number of 
osteoblast and hasten osteoblast in forming new bones. 
In conclusion, estradiol supplementation lowers bone 
resorption activity and increase bone formation activity.  
The combination of calcitriol ethynil ethyl estradiol 
suplementation on OVDE rats caused rats OVDE to 
have higher amount of adipose tissue within their bone 
marrow cavity and higher number of trabeculae spicules 
than OVK rats (Figure 3). The lesser amount of adipose 
tissue in the bone marrow cavity of OVDE rats 
compared to that of OVK rats but greater than NK rats 
revealed that the combination of calcitriol and ethynil 




ethyl estradiol suplementation caused the bone 
resorption activity of OVDE rats to become lower than 
OVK rats, but higher than NK rats. The higher number 
of trabecular spicules on femur  distal epiphyseal plate 
of OVDE rats than in OVK rats and NK rats were 
showed an increment of bone formation process of 
OVDE  rats than in OVK rats and NK rats. Adipose 
tissue in bone marrow cavity of OVDE rats was looked 
abundant than in NK rats, meanwhile, adipose tissue in 
OVDE rats looked fewer than OVK rats. These 
differences might be due to the higher number of 
estrogen found in OVDE rats than OVK rats. The more 
number of trabecular spicules in distal femoral 
epiphysis of OVDE rats than OVK rats was assumed 
related with the higher number of 1,25-
dihydroxyvitamin D3 and estrogen of OVDE rats than 
OVK rats. Furthermore, the more number of trabecular 
spicules in distalis femoral epiphysis of OVDE rats 
than NK rats is assumed related with higher number of 
1,25-dihydroxyvitamin D3 and estrogen of OVDE rats 
than NK rats. According to the result, it showed that the 
combination of calcitriol and ethynil ethyl estradiol in 
OVDE rats causes bone resorption activity of OVDE 
rats lower than OVK rats, but higher than NK rats, and 
causes bone formation activities of OVDE rats higher 




It can be concluded that the combination of 
calcitriol 20 g/day/rat and ethynil ethyl estradiol 25 
µg/day/rat administered orally for 8 weeks in 
ovariectomized rats lower osteoporosis risk but 
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